Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study.

Durier C, Desaint C, Lelièvre JD, Silbermann B, Pialoux G, Cuzin L, Bonnet B, Poizot-Martin I, Bouakane A, Paul C, Grabar S, Spire B, Meyer L, Launay O; ANRS/VRI COHVAC Study Group.

AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002310. [Epub ahead of print]

PMID:
31306171
2.

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.

Vieillard V, Combadière B, Tubiana R, Launay O, Pialoux G, Cotte L, Girard PM, Simon A, Dudoit Y, Reynes J, Rockstroh J, Garcia F, Gatell J, Devidas A, Yazdanpanah Y, Weiss L, Fätkenheuer G, Autran B, Joyeux D, Gharakhanian S, Debré P, Katlama C.

NPJ Vaccines. 2019 Jun 3;4:25. doi: 10.1038/s41541-019-0117-5. eCollection 2019. Erratum in: NPJ Vaccines. 2019 Aug 13;4:36.

3.

First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabine.

Siguier M, Mera R, Pialoux G, Ohayon M, Cotte L, Valin N, Ghosn J, Cua E, Pintado C, Chas J, Barriere G, Durand F, Molina JM.

J Antimicrob Chemother. 2019 Sep 1;74(9):2752-2758. doi: 10.1093/jac/dkz220.

PMID:
31219561
4.

Uncommon Detection of Mixed HCV Genotype Infections in Recently Infected Men Who Have Sex with Men.

Nguyen T, Delaugerre C, Valantin MA, Amiel C, Netzer E, L'Yavanc T, Ohayon M, Israel G, Valin N, Day N, Kreplak G, Pialoux G, Calvez V, Molina JM, Marcelin AG, Todesco E.

Int J Antimicrob Agents. 2019 Jun 11. pii: S0924-8579(19)30142-6. doi: 10.1016/j.ijantimicag.2019.06.001. [Epub ahead of print]

PMID:
31195120
5.

Shared HCV Transmission Networks Among HIV-1-Positive and HIV-1-Negative Men Having Sex With Men by Ultradeep Sequencing.

Nguyen T, Delaugerre C, Valantin MA, Amiel C, Netzer E, Lʼyavanc T, Ohayon M, Valin N, Day N, Kreplak G, Pialoux G, Calvez V, Molina JM, Marcelin AG, Todesco E.

J Acquir Immune Defic Syndr. 2019 Sep 1;82(1):105-110. doi: 10.1097/QAI.0000000000002099.

PMID:
31169768
6.

Community-Based Care in the ANRS-IPERGAY Trial: The Challenges of Combination Prevention.

Puppo C, Mabire X, Cotte L, Castro DR, Spire B, Cua E, Pialoux G, Monti MS, Pasquet A, Raffi F, Molina JM, Préau M; ANRS-Ipergay Study Group.

AIDS Educ Prev. 2019 Jun;31(3):259-272. doi: 10.1521/aeap.2019.31.3.259.

PMID:
31145006
7.

Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals.

Januel E, Godin O, Moulignier A, Lescure FX, Savatovsky J, Lamirel C, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D, Assoumou L; Microvascular Brain Retina And Kidney (MicroBREAK) Study Group.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):547-551. doi: 10.1097/QAI.0000000000002084.

PMID:
31107300
8.

Prevalence of tubulopathy and association with renal function loss in HIV-infected patients.

Lescure FX, Fellahi S, Pialoux G, Bastard JP, Eme AL, Esteve E, Lebrette MG, Guiard-Schmid JB, Capeau J, Ronco P, Costagliola D, Plaisier E.

Nephrol Dial Transplant. 2019 May 9. pii: gfz081. doi: 10.1093/ndt/gfz081. [Epub ahead of print]

PMID:
31071216
9.

In-depth Sampling of High-risk Populations to Characterize HIV Transmission Epidemics Among Young MSM Using PrEP in France and Quebec.

Chaillon A, Delaugerre C, Brenner B, Armero A, Capitant C, Nere ML, Leturque N, Pialoux G, Cua E, Tremblay C, Smith DM, Goujard C, Meyer L, Molina JM, Chaix ML.

Open Forum Infect Dis. 2019 Feb 15;6(3):ofz080. doi: 10.1093/ofid/ofz080. eCollection 2019 Mar.

10.

Meningococcal purpura fulminans and severe myocarditis with clinical meningitis but no meningeal inflammation: a case report.

Hage-Sleiman M, Derre N, Verdet C, Pialoux G, Gaudin O, Senet P, Fartoukh M, Boissan M, Garnier M.

BMC Infect Dis. 2019 Mar 12;19(1):252. doi: 10.1186/s12879-019-3866-x.

11.

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.

Shili-Masmoudi S, Sogni P, de Ledinghen V, Esterle L, Valantin MA, Poizot-Martin I, Simon A, Rosenthal E, Lacombe K, Pialoux G, Bouchaud O, Gervais-Hasenknoff A, Goujard C, Piroth L, Zucman D, Dominguez S, Raffi F, Alric L, Bani-Sadr F, Lascoux-Combe C, Garipuy D, Miailhes P, Vittecoq D, Duvivier C, Aumaître H, Neau D, Morlat P, Dabis F, Salmon D, Wittkop L; ANRS CO13 HEPAVIH study group.

PLoS One. 2019 Jan 25;14(1):e0211286. doi: 10.1371/journal.pone.0211286. eCollection 2019.

12.

Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial.

Chaix ML, Charreau I, Pintado C, Delaugerre C, Mahjoub N, Cotte L, Capitant C, Raffi F, Cua E, Pialoux G, Tremblay C, Meyer L, Molina JM; ANRS IPERGAY Study Group .

Open Forum Infect Dis. 2018 Nov 8;5(11):ofy295. doi: 10.1093/ofid/ofy295. eCollection 2018 Nov.

13.

CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.

Roul H, Mary-Krause M, Ghosn J, Delaugerre C, Pialoux G, Cuzin L, Launay O, Lacombe JM, Menard A, De Truchis P, Delfraissy JF, Weiss L, Costagliola D; FHDH-ANRS CO4.

AIDS. 2018 Nov 13;32(17):2605-2614. doi: 10.1097/QAD.0000000000002010.

PMID:
30289817
14.

Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY Trial.

Roux P, Fressard L, Suzan-Monti M, Chas J, Sagaon-Teyssier L, Capitant C, Meyer L, Tremblay C, Rojas-Castro D, Pialoux G, Molina JM, Spire B.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):e69-e75. doi: 10.1097/QAI.0000000000001781.

PMID:
30212434
15.

Drug resistance among patients who acquired HIV infection in a preexposure prophylaxis trial.

Delaugerre C, Rodriguez C, Capitant C, Nere ML, Mercier-Darty M, Carette D, Pialoux G, Cotte L, Charreau I, Molina JM; IPERGAY study group.

AIDS. 2018 Oct 23;32(16):2353-2361. doi: 10.1097/QAD.0000000000001960.

PMID:
30096070
16.

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort).

Yaya I, Marcellin F, Costa M, Morlat P, Protopopescu C, Pialoux G, Santos ME, Wittkop L, Esterle L, Gervais A, Sogni P, Salmon-Ceron D, Carrieri MP; ANRS CO13-HEPAVIH Cohort Study Group.

Nutrients. 2018 May 31;10(6). pii: E705. doi: 10.3390/nu10060705.

17.

Response to the Hammoud et al paper on 'the new MTV generation'.

Gafos M, Chas J, Pialoux G.

Int J Drug Policy. 2018 May;55:205-206. doi: 10.1016/j.drugpo.2018.01.015. Epub 2018 Feb 1. No abstract available.

18.

Factors associated with partner notification of STIs in men who have sex with men on PrEP in France: a cross-sectional substudy of the ANRS-IPERGAY trial.

Suzan-Monti M, Cotte L, Fressard L, Cua E, Capitant C, Meyer L, Pialoux G, Molina JM, Spire B; ANRS IPERGAY Study Group.

Sex Transm Infect. 2018 Nov;94(7):490-493. doi: 10.1136/sextrans-2017-053304. Epub 2018 Jan 29.

PMID:
29378903
19.

Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.

Cez A, Brocheriou I, Lescure FX, Adam C, Girard PM, Pialoux G, Moestrup SK, Fellahi S, Bastard JP, Ronco P, Plaisier E.

Hum Pathol. 2018 Mar;73:89-101. doi: 10.1016/j.humpath.2017.12.018. Epub 2018 Jan 5.

PMID:
29309806
20.

Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?

Januel E, Martin-Blondel G, Lamirel C, Picard H, Pialoux G, Katlama C, Cochereau I, Lescure FX, Moulignier A.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1125-1126. doi: 10.1136/jnnp-2017-317203. Epub 2018 Jan 5. No abstract available.

PMID:
29305436
21.

Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals.

Moulignier A, Savatovsky J, Assoumou L, Lescure FX, Lamirel C, Godin O, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Abrivard M, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D; Microvascular Brain Retina and Kidney (MicroBREAK) Study Group.

Clin Infect Dis. 2018 May 17;66(11):1762-1769. doi: 10.1093/cid/cix1075.

PMID:
29244126
22.

Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.

Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, Capitant C, Rojas-Castro D, Fonsart J, Bercot B, Bébéar C, Cotte L, Robineau O, Raffi F, Charbonneau P, Aslan A, Chas J, Niedbalski L, Spire B, Sagaon-Teyssier L, Carette D, Mestre SL, Doré V, Meyer L; ANRS IPERGAY Study Group.

Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8.

PMID:
29229440
23.

Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.

Durand-Zaleski I, Mutuon P, Charreau I, Tremblay C, Rojas D, Pialoux G, Chidiac C, Capitant C, Spire B, Cotte L, Chas J, Meyer L, Molina JM; ANRS IPERGAY Study Group.

AIDS. 2018 Jan 2;32(1):95-102. doi: 10.1097/QAD.0000000000001658.

PMID:
29210777
24.

HIV is associated with airway obstruction: a matched controlled study.

Makinson A, Hayot M, Eymard-Duvernay S, Ribet C, Raffi F, Pialoux G, Zucman D, Poizot-Martin I, Bonnet F, Abgrall S, Tattevin P, Cheret A, Ferry T, Mauboussin JM, Marchand L, Rouzaud C, Reynes J, Zins M, Le Moing V; ANRS EP48 HIV CHEST study Team.

AIDS. 2018 Jan 14;32(2):227-232. doi: 10.1097/QAD.0000000000001691.

PMID:
29135582
25.

Imported malaria in pregnant women: report from a French University Centre.

Develoux M, Le Loup G, Lafon-Desmurs B, Magne D, Belkadi G, Daray E, Pialoux G, Hennequin C.

Infection. 2018 Feb;46(1):119-122. doi: 10.1007/s15010-017-1078-0. Epub 2017 Oct 20.

PMID:
29058125
26.

Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4.

Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, Costagliola D.

PLoS One. 2017 Oct 2;12(10):e0184441. doi: 10.1371/journal.pone.0184441. eCollection 2017.

27.

Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression.

Supervie V, Assoumou L, Breban R, Lert F, Costagliola D, Pialoux G, Landman R, Girard PM, Slama L; IMEA 040 DATA Study Group.

J Antimicrob Chemother. 2017 Nov 1;72(11):3172-3176. doi: 10.1093/jac/dkx276.

PMID:
28961977
28.

NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147.

Gondois-Rey F, Chéret A, Granjeaud S, Mallet F, Bidaut G, Lécuroux C, Ploquin M, Müller-Trutwin M, Rouzioux C, Avettand-Fenoël V, Moretta A, Pialoux G, Goujard C, Meyer L, Olive D.

Clin Transl Immunology. 2017 Jul 7;6(7):e150. doi: 10.1038/cti.2017.22. eCollection 2017 Jul.

29.

Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy.

Moulignier A, Lamirel C, Picard H, Lebrette MG, Amiel C, Hamidi M, Polivka M, Mikol J, Cochereau I, Pialoux G.

Neurology. 2017 Aug 22;89(8):796-804. doi: 10.1212/WNL.0000000000004265. Epub 2017 Jul 26.

PMID:
28747447
30.

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.

Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L; ANRS IPERGAY Study Group.

Lancet HIV. 2017 Sep;4(9):e402-e410. doi: 10.1016/S2352-3018(17)30089-9. Epub 2017 Jul 23.

PMID:
28747274
31.

Cost-effectiveness of dolutegravir/abacavir/lamivudine in HIV-1 treatment-Naive (TN) patients in France.

Pialoux G, Marcelin AG, Cawston H, Guilmet C, Finkielsztejn L, Laurisse A, Aubin C.

Expert Rev Pharmacoecon Outcomes Res. 2018 Feb;18(1):83-91. doi: 10.1080/14737167.2017.1359542. Epub 2017 Jul 31.

PMID:
28741965
32.

Impact of early cART on HIV blood and semen compartments at the time of primary infection.

Chéret A, Durier C, Mélard A, Ploquin M, Heitzmann J, Lécuroux C, Avettand-Fenoël V, David L, Pialoux G, Chennebault JM, Müller-Trutwin M, Goujard C, Rouzioux C, Meyer L; ANRS OPTIPRIM study group.

PLoS One. 2017 Jul 14;12(7):e0180191. doi: 10.1371/journal.pone.0180191. eCollection 2017.

33.

Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis Programs.

Delaugerre C, Antoni G, Mahjoub N, Pialoux G, Cua E, Pasquet A, Hall N, Tremblay C, Cotte L, Capitant C, Chaix ML, Meyer L, Molina JM; IPERGAY Study Group.

J Infect Dis. 2017 Aug 1;216(3):382-386. doi: 10.1093/infdis/jix297.

PMID:
28666370
34.

A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART.

Gondois-Rey F, Chéret A, Mallet F, Bidaut G, Granjeaud S, Lécuroux C, Ploquin M, Müller-Trutwin M, Rouzioux C, Avettand-Fenoël V, De Maria A, Pialoux G, Goujard C, Meyer L, Olive D.

Front Immunol. 2017 Feb 10;8:54. doi: 10.3389/fimmu.2017.00054. eCollection 2017.

35.

Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies.

Chaillon A, Essat A, Frange P, Smith DM, Delaugerre C, Barin F, Ghosn J, Pialoux G, Robineau O, Rouzioux C, Goujard C, Meyer L, Chaix ML; on behalf the ANRS PRIMO Cohort Study.

Retrovirology. 2017 Feb 21;14(1):15. doi: 10.1186/s12977-017-0339-4.

36.

Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial.

Rockstroh JK, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Zhang-Roper R, Wang R, Pineda JA, Heera J.

Antivir Ther. 2017;22(3):263-269. doi: 10.3851/IMP3116. Epub 2016 Dec 7.

PMID:
27924779
37.

Imported filariasis in Europe: A series of 31 cases from Metropolitan France.

Develoux M, Hennequin C, Le Loup G, Paris L, Magne D, Belkadi G, Pialoux G.

Eur J Intern Med. 2017 Jan;37:e37-e39. doi: 10.1016/j.ejim.2016.09.021. Epub 2016 Oct 10. No abstract available.

PMID:
27733303
38.

Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection?

Pialoux G, Delaugerre C, Cotte L, Raffi F, Cua E, Molina JM.

Clin Microbiol Infect. 2016 Sep;22(9):757-767. doi: 10.1016/j.cmi.2016.08.029. Epub 2016 Sep 8. Review.

39.

Bacterial chondritis complications following ear piercing.

Bellaud G, Canestri A, Gallah S, Merlant M, Cousseau S, Lebrette MG, Slama L, Pialoux G.

Med Mal Infect. 2017 Feb;47(1):26-31. doi: 10.1016/j.medmal.2016.07.002. Epub 2016 Sep 3.

PMID:
27596713
40.

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).

Slama L, Landman R, Assoumou L, Benalycherif A, Samri A, Joly V, Pialoux G, Valin N, Cabié A, Duvivier C, Lambert-Niclot S, Marcelin AG, Peytavin G, Costagliola D, Girard PM; IMEA 040 DATA Study Group.

J Antimicrob Chemother. 2016 Aug;71(8):2252-61. doi: 10.1093/jac/dkw103. Epub 2016 Apr 10.

PMID:
27068399
41.

A Finger-Stick Whole-Blood HIV Self-Test as an HIV Screening Tool Adapted to the General Public.

Prazuck T, Karon S, Gubavu C, Andre J, Legall JM, Bouvet E, Kreplak G, Teglas JP, Pialoux G.

PLoS One. 2016 Feb 16;11(2):e0146755. doi: 10.1371/journal.pone.0146755. eCollection 2016.

42.

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.

Dinges W, Girard PM, Podzamczer D, Brockmeyer NH, García F, Harrer T, Lelievre JD, Frank I, Colin De Verdière N, Yeni GP, Ortega Gonzalez E, Rubio R, Clotet Sala B, DeJesus E, Pérez-Elias MJ, Launay O, Pialoux G, Slim J, Weiss L, Bouchaud O, Felizarta F, Meurer A, Raffi F, Esser S, Katlama C, Koletar SL, Mounzer K, Swindells S, Baxter JD, Schneider S, Chas J, Molina JM, Koutsoukos M, Collard A, Bourguignon P, Roman F.

Medicine (Baltimore). 2016 Feb;95(6):e2673. doi: 10.1097/MD.0000000000002673.

43.

Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral Agents.

Rockstroch JK, Soriano V, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Mukwaya G, Jagannatha S, Heera J, Pineda JA.

HIV Clin Trials. 2015 Nov;16(6):236-7. doi: 10.1080/15284336.2015.1124625. No abstract available.

PMID:
26777796
44.

Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men.

Slama L, Jacobson LP, Li X, Palella FJ Jr, Margolick JB, Kingsley LA, Wiley DJ, Pialoux G, Dobs AS, Brown TT; Multicenter AIDS Cohort Study.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):57-64. doi: 10.1097/QAI.0000000000000821.

45.

Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France.

Pialoux G, Marcelin AG, Despiégel N, Espinas C, Cawston H, Finkielsztejn L, Laurisse A, Aubin C.

PLoS One. 2015 Dec 29;10(12):e0145885. doi: 10.1371/journal.pone.0145885. eCollection 2015.

46.

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF; ANRS IPERGAY Study Group.

N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1.

47.

Does HIV Infection Alter Parkinson Disease?

Moulignier A, Gueguen A, Lescure FX, Ziegler M, Girard PM, Cardon B, Pialoux G, Molina JM, Brandel JP, Lamirel C.

J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):129-36. doi: 10.1097/QAI.0000000000000677.

PMID:
26371610
48.

The Day-Hospital of the University Hospital, Bobo Dioulasso: An Example of Optimized HIV Management in Southern Burkina Faso.

Chas J, Hema A, Slama L, Kabore NF, Lescure FX, Fontaine C, Pialoux G, Sawadogo A.

PLoS One. 2015 May 13;10(5):e0125588. doi: 10.1371/journal.pone.0125588. eCollection 2015.

49.

Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents.

Rockstroh JK, Soriano V, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Mukwaya G, Jagannatha S, Heera J, Pineda JA.

HIV Clin Trials. 2015 Mar-Apr;16(2):72-80. doi: 10.1179/1528433614Z.0000000011. Erratum in: HIV Clin Trials. 2015 Nov;16(6):236-8.

50.

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Aug 15;61(4):593-600. doi: 10.1093/cid/civ333. Epub 2015 Apr 22.

PMID:
25904368

Supplemental Content

Loading ...
Support Center